Intrinsic Value of S&P & Nasdaq Contact Us

Kamada Ltd. KMDA NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
78/100
4/7 Pass
SharesGrow Intrinsic Value
$19.68
+133.7%
Analyst Price Target
$12.00
+42.5%

Kamada Ltd. (KMDA) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 5 Buy, 1 Hold.

The consensus price target is $12.00 (low: $11.00, high: $13.00), representing an upside of 42.5% from the current price $8.42.

Analysts estimate Earnings Per Share (EPS) of $0.24 and revenue of $0.16B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.26 vs est $0.24 (beat +6.9%). 2025: actual $0.38 vs est $0.37 (beat +3.4%). Analyst accuracy: 95%.

KMDA Stock — 12-Month Price Forecast

$12.00
▲ +42.52% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for Kamada Ltd., the average price target is $12.00, with a high forecast of $13.00, and a low forecast of $11.00.
The average price target represents a +42.52% change from the last price of $8.42.
Highest Price Target
$13.00
Average Price Target
$12.00
Lowest Price Target
$11.00

KMDA Analyst Ratings

Buy
6
Ratings
5 Buy
1 Hold
Based on 6 analysts giving stock ratings to Kamada Ltd. in the past 3 months
Rating breakdown
Buy
5 83%
Hold
1 17%
83%
Buy
5 analysts
17%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — KMDA

95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.26 vs Est $0.24 ▲ 6.4% off
2025 Actual $0.38 vs Est $0.37 ▲ 3.3% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.

Revenue Estimates — KMDA

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.161B vs Est $0.161B ▼ 0.2% off
2025 Actual $0.195B vs Est $0.181B ▲ 7.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message